Critic suggests Health Canada lacks guts to pull drug

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1338卷 / 1期

关键词：

Rosiglitazone; Pioglitazone; Marketing Authorisation; News Item; Safety Communication;

D O I：

10.2165/00128415-201113380-00006

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Health official speaks out about row over drug critic
Meredith Wadman
Nature, 2007, 449 : 952 - 953
[2] Health official speaks out about row over drug critic
Wadman, Meredith
NATURE, 2007, 449 (7165) : 952 - 953
[3] Drug regulation - Health Canada to publish reasons for drug approvals
Eggertson, L
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (11) : 1431 - 1431
[4] Health Canada shifts focus on drug regulation
Reactions Weekly, 2007, 1163 (1) : 1 - 1
[5] Health Canada "harmonizing down" on drug regulations
Vogel, Lauren
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (04) : E230 - E230
[6] Health Canada to improve drug recall process
Cross, Catherine
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (18) : E811 - E812
[7] Drug Insurance - The connection between drug insurance, drug use and health in Canada
Kunde, Katharina
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2023, 28 (05): : 206 - 206
[8] Info on paediatric drug safety released by Health Canada
Reactions Weekly, 2012, 1386 (1) : 3 - 3
[9] Health Canada assesses risk of drug interactions with Jakavi
Reactions Weekly, 2018, 1724 (1) : 1 - 1
[10] Health Canada "passes the buck" on diabetes drug, researcher charges
Eggertson, Laura
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (02) : E75 - E76

← 1 2 3 4 5 →